These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9682250)

  • 1. Direct effect of branched-chain amino acids on the growth and metabolism of cultured human hepatocellular carcinoma cells.
    Sugiyama K; Yu L; Nagasue N
    Nutr Cancer; 1998; 31(1):62-8. PubMed ID: 9682250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the molar ratio of branched-chain to aromatic amino acids on growth and albumin mRNA expression of human liver cancer cell lines in a serum-free medium.
    Saito Y; Saito H; Nakamura M; Wakabayashi K; Takagi T; Ebinuma H; Ishii H
    Nutr Cancer; 2001; 39(1):126-31. PubMed ID: 11588894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Branched-chain amino acid deficiency stabilizes insulin-induced vascular endothelial growth factor mRNA in hepatocellular carcinoma cells.
    Miuma S; Ichikawa T; Arima K; Takeshita S; Muraoka T; Matsuzaki T; Ootani M; Shibata H; Akiyama M; Ozawa E; Miyaaki H; Taura N; Takeshima F; Nakao K
    J Cell Biochem; 2012 Oct; 113(10):3113-21. PubMed ID: 22581719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effects of tamoxifen on human hepatocellular carcinoma cell proliferation and transforming growth factor-beta1 expression].
    Shin JW; Chung YH; Park MI; Kim JA; Choi MH; Lee YJ; Ryu SH; Park NH; Lee HC; Lee YS; Suh DJ; Yu ES
    Taehan Kan Hakhoe Chi; 2003 Mar; 9(1):10-6. PubMed ID: 12657824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression.
    Jong HS; Lee HS; Kim TY; Im YH; Park JW; Kim NK; Bang YJ
    Biochem Biophys Res Commun; 2002 Mar; 292(2):383-9. PubMed ID: 11906173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor.
    Neaud V; Faouzi S; Guirouilh J; Le Bail B; Balabaud C; Bioulac-Sage P; Rosenbaum J
    Hepatology; 1997 Dec; 26(6):1458-66. PubMed ID: 9397985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular pH regulation in Hep G2 cells: effects of epidermal growth factor, transforming growth factor-alpha, and insulinlike growth factor-II on Na+/H+ exchange activity.
    Strazzabosco M; Poci C; Spirlì C; Zsembery A; Granato A; Massimino ML; Crepaldi G
    Hepatology; 1995 Aug; 22(2):588-97. PubMed ID: 7635429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Branched-chain amino acids prevent hepatic fibrosis and development of hepatocellular carcinoma in a non-alcoholic steatohepatitis mouse model.
    Takegoshi K; Honda M; Okada H; Takabatake R; Matsuzawa-Nagata N; Campbell JS; Nishikawa M; Shimakami T; Shirasaki T; Sakai Y; Yamashita T; Takamura T; Tanaka T; Kaneko S
    Oncotarget; 2017 Mar; 8(11):18191-18205. PubMed ID: 28212548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus vector expressing mda-7 selectively kills hepatocellular carcinoma cell line Hep3B.
    Xue XB; Chen K; Wang CJ; Zheng JW; Yu Y; Peng ZH; Wu ZD
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):509-14. PubMed ID: 18842498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of interferon regulatory factor 1 and S100C/A11 in growth inhibition by transforming growth factor beta 1 in human hepatocellular carcinoma cells.
    Miyazaki M; Sakaguchi M; Akiyama I; Sakaguchi Y; Nagamori S; Huh NH
    Cancer Res; 2004 Jun; 64(12):4155-61. PubMed ID: 15205326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptive regulation of amino acid transport in nutrient-deprived human hepatomas.
    Wasa M; Bode BP; Souba WW
    Am J Surg; 1996 Jan; 171(1):163-9. PubMed ID: 8554134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The growth inhibitory effects of vitamins K and their actions on gene expression.
    Wang Z; Wang M; Finn F; Carr BI
    Hepatology; 1995 Sep; 22(3):876-82. PubMed ID: 7657295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-beta1-induced cell growth arrest and partial differentiation is related to the suppression of Id1 in human hepatoma cells.
    Damdinsuren B; Nagano H; Kondo M; Natsag J; Hanada H; Nakamura M; Wada H; Kato H; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Monden M
    Oncol Rep; 2006 Feb; 15(2):401-8. PubMed ID: 16391861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of transforming growth factor-beta1 and transforming growth factor-beta receptors in hepatocellular carcinoma and dysplastic nodules.
    Paik SY; Park YN; Kim H; Park C
    Mod Pathol; 2003 Jan; 16(1):86-96. PubMed ID: 12527718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Branched-chain amino acids as pharmacological nutrients in chronic liver disease.
    Kawaguchi T; Izumi N; Charlton MR; Sata M
    Hepatology; 2011 Sep; 54(3):1063-70. PubMed ID: 21563202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autonomous growth in serum-free medium and production of hepatocellular carcinomas by differentiated hepatocyte lines that overexpress transforming growth factor alpha 1.
    Wu JC; Merlino G; Cveklova K; Mosinger B; Fausto N
    Cancer Res; 1994 Nov; 54(22):5964-73. PubMed ID: 7525051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells.
    Sugano Y; Matsuzaki K; Tahashi Y; Furukawa F; Mori S; Yamagata H; Yoshida K; Matsushita M; Nishizawa M; Fujisawa J; Inoue K
    Oncogene; 2003 Apr; 22(15):2309-21. PubMed ID: 12700666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of branched-chain amino acids and angiotensin-converting enzyme inhibitor suppresses the cumulative recurrence of hepatocellular carcinoma: a randomized control trial.
    Yoshiji H; Noguchi R; Ikenaka Y; Kaji K; Aihara Y; Yamazaki M; Yamao J; Toyohara M; Mitoro A; Sawai M; Yoshida M; Morioka C; Fujimoto M; Uemura M; Fukui H
    Oncol Rep; 2011 Dec; 26(6):1547-53. PubMed ID: 21874260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ethanol on glycerolipid and fatty acid metabolism in Hep G2 human-hepatoma cells.
    Angeletti C; de Alaniz MJ
    Acta Physiol Pharmacol Ther Latinoam; 1996; 46(2):57-69. PubMed ID: 8998370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical and nutraceutical approaches for preventing liver carcinogenesis: chemoprevention of hepatocellular carcinoma using acyclic retinoid and branched-chain amino acids.
    Shimizu M; Shirakami Y; Hanai T; Imai K; Suetsugu A; Takai K; Shiraki M; Moriwaki H
    Mol Nutr Food Res; 2014 Jan; 58(1):124-35. PubMed ID: 24273224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.